Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions
Coping After Breast Cancer - CABC - Stressmestring Etter Brystkreft - SEB
Norwegian Institute of Public Health
390 participants
Jan 15, 2021
INTERVENTIONAL
Conditions
Summary
1. Breast cancer patients and age-matched controls are first invited to answer questions on HRQoL. 2. Among responding breast cancer patients, a subset are invited in a randomized clinical trial with two digital interventions for cancer stress management, cognitive based stress management (CBSM) and mindfulness based intervention (MBI), as well as a control group. 3. The goal is to determine whether digital CBSM or MBI can effectively reduce stress levels as compared to a control group. Second, whether these interventions can improve HRQoL (or avoid onset of HRQoL problems) for patients with breast cancer, compared to a control group.
Eligibility
Inclusion Criteria6
- first occurrence breast cancer diagnosed from Jan 1, 2020
- non-metastatic cancer stage 0-III
- Invasive tumors must be:
- HER2 positive (regardless of ER, PR) or
- ER negative
- (may later include other ER+ if not conflict with recruitment for EMIT/OPTIMA)
Exclusion Criteria1
- None
Interventions
The participants will download an app (Stressproffen 2A) with cognitive based stress management.
The participants will download an app (Stressproffen 2B) with mindfulness based intervention.
The participants will receive no app. (They will be able to download it after the end of the 3 year study).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04480203